Skip to main content
Premium Trial:

Request an Annual Quote

ViaLogy

Premium

ViaLogy of Pasadena, Calif, a spinoff of ViaSpace Technologies, a technology commercialization company developed by the NASA/Caltech Jet Propulsion Laboratory, this week announced the launch of a microarray analysis service targeting large-scale users of microarrays. ViaLogy will launch services based on its quantum resonance interferometry (QRI) technology, a proprietary method that it says can amplify signals previously garbled by background interference.

The company will accept data files from existing microarray instrumentation and databases and reprocess it using its technology in a service available online on a pay-per-use basis, the company said in a statement. The online service will become available in December.

Results should be available within 24 hours, the company said.

The ViaLogy technology, based on concepts gleaned from aerospace research, allows the amplification of signals to enable the detection and quantification of hybridization events that other technologies might not perceive due to background noise.

ViaLogy’s microarray service is pre-calibrated and selectable for several different types of Affymetrix GeneChip technology and the company is adding capabilities for formats on glass slides.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.